Canara Robeco Emerging Equities: This fund shifted its positioning from a mid- and small-cap offering to its current large- and mid-cap mandate a few years ago

This large-and mid-cap equity mutual fund gave 18.5% returns in five years; should you invest? It retains preference for businesses with improving fundamentals or experiencing temporary setbacks. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision

ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

Canara Robeco Emerging Equities
.live_stock{left:17px;padding:1px 3px 1px 5px;font-size:12px;font-weight:600;line-height:18px;top:9px} #sr_widget .sr_desc{margin:0 auto 0;} #sr_widget .sr_desc{color: #024d99;margin-top:10px;} #sr_widget .crypto .live_stock .lb-icon{8px 6px 5px 3px !important} #sr_widget.crypto a.text{border-bottom:1px solid #ccc;padding-bottom:5px;display:block;width:100%} #sr_widget .sr_desc .text p, #stock_pro .sr_desc .text p{font-size:12px;font-weight:400;} Modi 3.0 Live
Modi Oath Ceremony Live
BASIC FACTS
DATE OF LAUNCH
11 MARCH 2005
CATEGORY
EQUITY
TYPE
LARGE & MIDCAP
AUM*
Rs.21,509 crore
BENCHMARK
NIFTY LARGE MIDCAP 250 TOTAL RETURN INDEX
im-1
WHAT IT COSTS
NAV**
GROWTH OPTION
Rs.225.09
IDCW
Rs.80.84
MINIMUM INVESTMENT
Rs.5,000
im-2MINIMUM SIP AMOUNT
Rs.1,000
im-3
EXPENSE RATIO# (%)
1.63
EXIT LOAD
1% for redemption within 365 days

im-4
im-5
*AS ON 30 APR 2024
**AS ON 5 JUNE 2024
#AS ON 30 APR 2024
im-6
FUND MANAGER
SHRIDATTA BHANDWALDAR
4 YEARS, 7 MONTHS

Recent portfolio changes
New entrants
Cello World, Central Depository Services (India), HCL Technologies, Hero Motocorp, LTIMindtree, Zomato (Mar). Container Corporation of India, GAIL (India), Hindalco Industries, Indian Energy Exchange, Info Edge (India), Muthoot Finance, Pidilite Industries, United Breweries (April).
Complete exits
Ashok Leyland, Eicher Motors, HCL Technologies, Infosys, Mphasis, Sundram Fasteners, Supreme Industries, Zydus Lifesciences (April).

Should you buy?
This fund shifted its positioning from a mid-and small-cap offering to its current large-and mid-cap mandate a few years ago. It retains preference for businesses with improving fundamentals or experiencing temporary setbacks. The fund manager places lot of emphasis on downside protection and limiting drawdowns, apart from maintaining liquidity hygiene checks. It has shed its large-cap tilt in favour of a more balanced market cap exposure, even as its portfolio size has expanded from sub-60 to 77 stocks. The fund’s long-term track record is impressive. In recent years, the fund has fared well compared to its index, but has lagged sharply behind many of its peers. The fund must improve its showing to be counted as a worthy offering in its category.
.live_stock{left:17px;padding:1px 3px 1px 5px;font-size:12px;font-weight:600;line-height:18px;top:9px} #sr_widget .sr_desc{margin:0 auto 0;} #sr_widget .sr_desc{color: #024d99;margin-top:10px;} #sr_widget .crypto .live_stock .lb-icon{8px 6px 5px 3px !important} #sr_widget.crypto a.text{border-bottom:1px solid #ccc;padding-bottom:5px;display:block;width:100%} #sr_widget .sr_desc .text p, #stock_pro .sr_desc .text p{font-size:12px;font-weight:400;}
This story originally appeared on: India Times - Author:Faqs of Insurances